Prognostic significance of RUNX3 expression in human melanoma.

Abstract:

BACKGROUND:RUNX3 is a tumor suppressor that plays important roles in cell proliferation, apoptosis, and metastasis. The authors investigated the role of RUNX3 in melanoma pathogenesis and analyzed the prognostic impact of RUNX3 expression in a large series of melanoma patients. METHODS:Two sets of tissue microarrays were constructed, including 440 cases of melanomas (202 for the training set and 238 for the validation set) and 88 cases of nevi (25 normal nevi and 63 dysplastic nevi). RUNX3 expression was evaluated by immunohistochemistry. RESULTS:Positive RUNX3 expression was observed in 56%, 54%, 33%, and 24% of the biopsies in normal nevi, dysplastic nevi, primary melanoma, and melanoma metastases, respectively. Significant differences for positive nuclear RUNX3 staining were observed between dysplastic nevi and primary melanomas (P = .002, chi-square test), between dysplastic nevi and melanoma metastases (P < .001, chi-square test), and between primary melanoma and melanoma metastases (P = .045, chi-square test). Loss of RUNX3 expression was correlated with a worse 5-year survival of melanoma patients in both training and validation sets. Furthermore, loss of RUNX3 expression was also correlated with a poor 5-year disease-specific survival in primary melanoma (P = .001) and metastatic melanoma patients (P = .008). Multivariate Cox regression analysis revealed that positive RUNX3 expression is an independent prognostic factor to predict melanoma patient outcome. CONCLUSIONS:Our findings indicate that RUNX3 plays an important role in melanoma pathogenesis and may serve as a promising prognostic marker for melanoma.

journal_name

Cancer

journal_title

Cancer

authors

Zhang Z,Chen G,Cheng Y,Martinka M,Li G

doi

10.1002/cncr.25838

subject

Has Abstract

pub_date

2011-06-15 00:00:00

pages

2719-27

issue

12

eissn

0008-543X

issn

1097-0142

journal_volume

117

pub_type

杂志文章

相关文献

CANCER文献大全
  • Bizarre (pseudomalignant) granulation-tissue reactions following ionizing-radiation exposure. A microscopic, immunohistochemical, and flow-cytometric study.

    abstract::Two patients developed extremely bizarre (pseudomalignant) granulation-tissue reactions in the larynx and facial sinuses, following radiation therapy for carcinoma. Containing pleomorphic spindle cells and numerous (sometimes atypical) mitotic figures, both tumefactive lesions simulated high grade malignancies. While ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870415)59:8<1509::aid-cncr2820

    authors: Weidner N,Askin FB,Berthrong M,Hopkins MB,Kute TE,McGuirt FW

    更新日期:1987-04-15 00:00:00

  • Non-Hodgkin's lymphoma in children.

    abstract::Until recently the prognosis of childhood non-Hodgkin's lymphoma has been poor. A program of combination chemotherapy and involved area radiotherapy was instituted in the Department of Pediatrics at Roswell Park Memorial Institute in 1971. Thirty-one biopsy proven untreated children entered this study. There were 4 St...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197805)41:5<1997::aid-cncr282041

    authors: Brecher ML,Sinks LF,Thomas RR,Freeman AI

    更新日期:1978-05-01 00:00:00

  • Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate.

    abstract:BACKGROUND:Menorrhagia is a serious complication in young female oncology patients who suffer from severe thrombocytopenia during myelosuppressive treatment. To the authors' knowledge, little is known regarding the incidence of this complication or the effectiveness of possible therapies for its prevention. METHODS:In...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22199

    authors: Meirow D,Rabinovici J,Katz D,Or R,Shufaro Y,Ben-Yehuda D

    更新日期:2006-10-01 00:00:00

  • Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials.

    abstract:BACKGROUND:The measurement of estrogen receptors (ER) in breast cancer specimens has traditionally been assessed with a dextran-coated charcoal assay (DCCA). More recently the immunohistochemical staining (IHC) method has gained increasing popularity because of its ability to use fixed tissue, assess needle biopsies, a...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/(SICI)1097-0142(19960815)78:4<764::AID-CNC

    authors: Alberts SR,Ingle JN,Roche PR,Cha SS,Wold LE,Farr GH Jr,Krook JE,Wieand HS

    更新日期:1996-08-15 00:00:00

  • Diagnosis and management of microinvasive (stage IA) carcinoma of the uterine cervix.

    abstract::One hundred and sixty-two cases of Stage IA microinvasive carcinoma of the cervix are presented. These patients represent the combined experience at the University of Miami School of Medicine, Miami, Florida, and Downstate Medical Center, Brooklyn, New York. The criteria used in both institutions are 1) penetration of...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197607)38:1<414::aid-cncr2820380

    authors: Averette HE,Nelson JH Jr,Ng AB,Hoskins WJ,Boyce JG,Ford JH Jr

    更新日期:1976-07-01 00:00:00

  • Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials.

    abstract:BACKGROUND:Fulvestrant (ICI 182,780) is a new type of estrogen receptor (ER) antagonist that down-regulates the ER and has no known agonist effects. The authors report the prospectively planned combined analysis of data from 2 Phase III trials comparing fulvestrant 250 mg monthly (n=428) and anastrozole 1 mg daily (n=4...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1002/cncr.11468

    authors: Robertson JF,Osborne CK,Howell A,Jones SE,Mauriac L,Ellis M,Kleeberg UR,Come SE,Vergote I,Gertler S,Buzdar A,Webster A,Morris C

    更新日期:2003-07-15 00:00:00

  • Chemotherapy for adenocystic carcinoma.

    abstract::Seventeen patients with adenocystic carcinoma have received 34 adequate trials of chemotherapy at Princess Margaret Hospital since 1969. There have been five objective responses to chemotherapy in 4 cases, lasting from five to 24 months, and 3 other patients have had stabilized disease for a period of five to seven mo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800801)46:3<452::aid-cncr28204

    authors: Tannock IF,Sutherland DJ

    更新日期:1980-08-01 00:00:00

  • Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.

    abstract:BACKGROUND:Ovarian cancer patients frequently receive chemotherapy near the end of life. The purpose of the current study was to develop indicators that characterize those ovarian cancer patients who have a short life span. METHODS:The medical charts of deceased epithelial ovarian cancer patients were retrospectively ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.23391

    authors: von Gruenigen V,Daly B,Gibbons H,Hutchins J,Green A

    更新日期:2008-05-15 00:00:00

  • The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children's Research Hospital Experience.

    abstract:BACKGROUND:It remains unclear whether primary tumor resection benefits patients with metastatic neuroblastoma. The authors assessed the impact of extent and timing of resection on outcome in these patients. METHODS:The authors reviewed the records of 124 patients > 1 year of age at diagnosis of International Neuroblas...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21566

    authors: McGregor LM,Rao BN,Davidoff AM,Billups CA,Hongeng S,Santana VM,Hill DA,Fuller C,Furman WL

    更新日期:2005-12-15 00:00:00

  • The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.

    abstract:BACKGROUND:Patients' estimates of their chances of therapeutic benefit from participation in early phase trials greatly exceed historical data. Ethicists worry that this therapeutic misestimation undermines the validity of informed consent. METHODS:The authors interviewed 45 patients enrolled in phase 1 or 2 oncology ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25201

    authors: Sulmasy DP,Astrow AB,He MK,Seils DM,Meropol NJ,Micco E,Weinfurt KP

    更新日期:2010-08-01 00:00:00

  • Treatment of children with neurogenic sarcoma. Experience at the Children's Hospital of Philadelphia, 1958-1984.

    abstract::Twenty-four children aged 3 months to 18 years (median, 12 years) were treated for neurogenic sarcoma at the Children's Hospital of Philadelphia Cancer Research Center from 1958 through 1984. Sixteen patients had neurofibromatosis (NF). The tumors arose in an extremity or in the trunk (15 patients), the retroperitoneu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870101)59:1<1::aid-cncr2820590

    authors: Raney B,Schnaufer L,Ziegler M,Chatten J,Littman P,Jarrett P

    更新日期:1987-01-01 00:00:00

  • Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.

    abstract:BACKGROUND:Splenic and nodal marginal zone lymphomas (MZL) are subtypes of marginal zone-derived neoplasms. Due to their rarity, little is known concerning their relation, pattern of dissemination, and treatment outcome. METHODS:The authors analyzed the clinicopathologic features and outcome of 43 patients (34 patient...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11893

    authors: Arcaini L,Paulli M,Boveri E,Vallisa D,Bernuzzi P,Orlandi E,Incardona P,Brusamolino E,Passamonti F,Burcheri S,Schena C,Pascutto C,Cavanna L,Magrini U,Lazzarino M

    更新日期:2004-01-01 00:00:00

  • Thyroid abnormalities following neck irradiation for Hodgkin's disease.

    abstract::Thyroid function and scans were evaluated in fifty disease-free patients 2 to 16 years after receiving neck irradiation for the treatment of Hodgkin's disease. Twenty-five of 50 patients had abnormal thyroid studies: eight were hypothyroid, two were hypothyroid and had abnormal scans, and fifteen had abnormal scans. O...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197812)42:6<2553::aid-cncr282042

    authors: Nelson DF,Reddy KV,O'Mara RE,Rubin P

    更新日期:1978-12-01 00:00:00

  • Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma.

    abstract:BACKGROUND:Recently, the authors identified molecular signatures and pathways associated with nonsmall cell lung carcinoma histology and lung development. They hypothesized that genetic classifiers of histology would provide insight into lung tumorigenesis and would be associated with clinical outcome when evaluated in...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20542

    authors: Shah L,Walter KL,Borczuk AC,Kawut SM,Sonett JR,Gorenstein LA,Ginsburg ME,Steinglass KM,Powell CA

    更新日期:2004-10-01 00:00:00

  • Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.

    abstract:BACKGROUND:Capecitabine with oxaliplatin (CAPOX) has previously demonstrated clinical activity in patients with small bowel adenocarcinoma (SBA) and ampullary adenocarcinoma (AAC). Herein, the authors conducted a phase 2 trial to evaluate the benefit of adding bevacizumab to CAPOX. METHODS:In this phase 2, single-arm,...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30445

    authors: Gulhati P,Raghav K,Shroff RT,Varadhachary GR,Kopetz S,Javle M,Qiao W,Wang H,Morris J,Wolff RA,Overman MJ

    更新日期:2017-05-15 00:00:00

  • A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.

    abstract::Sixteen patients with metastatic neuroendocrine tumors and the malignant carcinoid syndrome were treated with cyproheptadine (Periactin, Merck, Sharp & Dohme, West Point, PA) at maximum tolerable doses that ranged from 12 to 48 mg daily. Usual side effects were mild sedation and dry mouth, but three patients found it ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19910101)67:1<33::aid-cncr282067

    authors: Moertel CG,Kvols LK,Rubin J

    更新日期:1991-01-01 00:00:00

  • Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression.

    abstract:BACKGROUND:Disruption of the lymphatic circulation through breast carcinoma-associated axillary lymph node dissection, with or without radiation therapy, reportedly is the most common cause of lymphedema in developed countries. There is no cure for breast carcinoma-associated lymphedema. Although intermittent pneumatic...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/cncr.10976

    authors: Szuba A,Achalu R,Rockson SG

    更新日期:2002-12-01 00:00:00

  • CEA tissue staining in colorectal cancer patients. A way to improve the usefulness of serial serum CEA evaluation.

    abstract::The evaluation of serial plasma carcinoembryonic antigen (CEA) levels is one of the most important parameter used to establish the prognosis of surgically cured colorectal cancer patients. Carcinoembryonic antigen is particularly useful in the identification of recurrences and metastasis. However, to improve the usefu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850601)55:11<2624::aid-cncr282

    authors: Midiri G,Amanti C,Benedetti M,Campisi C,Santeusanio G,Castagna G,Peronace L,Di Tondo U,Di Paola M,Pascal RR

    更新日期:1985-06-01 00:00:00

  • Acute nonlymphocytic leukemia 5 years after treatment with cisplatin, vinblastine, and bleomycin for disseminated testicular cancer.

    abstract::The combination of cisplatin, vinblastine, and bleomycin (PVB) was used to treat a 25-year-old man for disseminated testicular germ cell cancer, leading to a complete remission. Acute nonlymphocytic leukemia (ANLL), resistant to chemotherapy, developed 5 years later. The secondary nature of this ANLL was corroborated ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860301)57:5<984::aid-cncr28205

    authors: van Imhoff GW,Sleijfer DT,Breuning MH,Anders GJ,Mulder NH,Halie MR

    更新日期:1986-03-01 00:00:00

  • Breast carcinoma with noninflammatory skin involvement (T4b): time to abandon an historic relic from the TNM classification.

    abstract:BACKGROUND:In this study, the authors evaluated the clinical presentation of patients with T4b breast carcinoma, analyzed the impact of noninflammatory skin involvement on long-term survival, and addressed the question whether the T4 tumor category still has any justification. METHODS:The clinical course of a study gr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21394

    authors: Guth U,Wight E,Schotzau A,Langer I,Dieterich H,Rochlitz C,Herberich L,Holzgreve W,Singer G

    更新日期:2005-11-01 00:00:00

  • Ganglioneuroma presenting with differentiated skeletal metastases. Report of a case.

    abstract::The authors report the case of a child with retroperitoneal ganglioneuroma and cytodifferentiated skeletal metastases. The primary tumor was surgically resected, and the child is alive and well 2 years later without additional therapy. This rarely documented phenomenon can be explained by spontaneous cytomaturation wi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840715)54:2<357::aid-cncr28205

    authors: Garvin JH Jr,Lack EE,Berenberg W,Frantz CN

    更新日期:1984-07-15 00:00:00

  • Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study.

    abstract:BACKGROUND:Chemoradiation with 5-fluorouracil and mitomycin remains the standard of care for squamous cell carcinoma (SCC) of the anal canal. A prolonged treatment time is associated with inferior disease-specific outcomes. Radiation Therapy Oncology Group trial 0529 demonstrated decreased toxicity and fewer treatment ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31721

    authors: Elson JK,Kachnic LA,Kharofa JR

    更新日期:2018-11-15 00:00:00

  • A study on chronologic change of the relationship between cigarette smoking and lung cancer based on autopsy diagnosis.

    abstract::Human cases autopsied at the Department of Pathology, University of Tokyo, were studied to investigate the chronologic changes in the relationship between cigarette smoking and lung cancer occurrence. The results obtained were as follows: (1) it was confirmed that the incidence of lung cancer was significantly higher ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840915)54:6<1038::aid-cncr2820

    authors: Mori W,Sakai R

    更新日期:1984-09-15 00:00:00

  • Primary extramedullary esophageal plasmacytoma: First case report.

    abstract::Solitary extramedullary plasmacytomas are rare tumors, reported to occur most commonly in the upper respiratory passages, but which also are rarely seen in the middle and lower gastrointestinal system. This report documents the first primary plasmacytoma of the esophagus. A 67-year-old Caucasian man complained of dysp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197608)38:2<943::aid-cncr2820380

    authors: Ahmed N,Ramos S,Sika J,LeVeen HH,Piccone VA

    更新日期:1976-08-01 00:00:00

  • Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma.

    abstract:BACKGROUND:It has been reported that MUC1 is an important prognostic factor in several cancers. This study investigated the importance of MUC1 as a prognostic factor in mass-forming intrahepatic cholangiocarcinoma (m-ICC). METHODS:In 50 patients with m-ICC who had undergone hepatectomy, expression of MUC1 was investig...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10398

    authors: Matsumura N,Yamamoto M,Aruga A,Takasaki K,Nakano M

    更新日期:2002-03-15 00:00:00

  • Immune hemolytic anemia associated with streptococcal preparation OK-432.

    abstract::In the course of administration of an immunopotentiator, streptococcal agent OK-432, a patient with lung cancer was found to have severe anemia and a strongly positive antiglobulin test. In the absence of the drug, eluates from the patient's erythrocytes reacted strongly by the indirect antiglobulin test with a panel ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870415)59:8<1409::aid-cncr2820

    authors: Nomura S,Kanoh T

    更新日期:1987-04-15 00:00:00

  • Combination chemotherapy in abdominal Burkitt's lymphoma.

    abstract::In a clinical trial, 42 patients with abdominal Burkitt's lymphoma (BL) were treated with a combination regimen, code-named CVA, consisting of cyclophosphamide (CTX), vincristine, and cystosine arabinoside. In addition, intrathecal methotrexate (i.t. MTX) was administered as prophylaxis against subsequent central nerv...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197710)40:4<1410::aid-cncr282040

    authors: Nkrumah FK,Perkins IV,Biggar RJ

    更新日期:1977-10-01 00:00:00

  • Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.

    abstract:BACKGROUND:Sipuleucel-T is an investigational active cellular immunotherapy product designed to stimulate an immune response against prostate cancer. The safety and efficacy of sipuleucel-T was evaluated in 2 identically designed, randomized, double-blind, placebo-controlled trials (D9901 and D9902A) conducted in men w...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.24429

    authors: Higano CS,Schellhammer PF,Small EJ,Burch PA,Nemunaitis J,Yuh L,Provost N,Frohlich MW

    更新日期:2009-08-15 00:00:00

  • A spectrum of cytomorphologic variations in medullary thyroid carcinoma. Fine-needle aspiration findings in 19 cases.

    abstract:BACKGROUND:Medullary thyroid carcinoma (MTC), a rare malignancy with a variety of morphologic appearances, can mimic both primary and metastatic lesions of the thyroid gland and give rise to diagnostic problems when these tumors are aspirated. Although cytopathologic features of MTC have been well described, this study...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Green I,Ali SZ,Allen EA,Zakowski MF

    更新日期:1997-02-25 00:00:00

  • Imaging for improved prediction of myelotoxicity after radioimmunotherapy.

    abstract:BACKGROUND:The severity of myelotoxicity after radioimmunotherapy has been predicted from body and blood radiation doses to marrow. However, marrow radiation can be increased substantially if the marrow or skeleton contains the malignancy targeted by the radiolabeled monoclonal antibodies. A study of 29 patients treate...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19971215)80:12+<2558::aid-

    authors: DeNardo DA,DeNardo GL,O'Donnell RT,Lim SM,Shen S,Yuan A,DeNardo SJ

    更新日期:1997-12-15 00:00:00